1. Home
  2. BKU vs NVAX Comparison

BKU vs NVAX Comparison

Compare BKU & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

HOLD

Current Price

$45.13

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.75

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKU
NVAX
Founded
2009
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.1B
IPO Year
2011
1995

Fundamental Metrics

Financial Performance
Metric
BKU
NVAX
Price
$45.13
$6.75
Analyst Decision
Hold
Hold
Analyst Count
11
8
Target Price
$42.73
$9.75
AVG Volume (30 Days)
1.0M
3.3M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
2.74%
N/A
EPS Growth
44.85
N/A
EPS
3.54
2.07
Revenue
$1,016,093,000.00
$1,064,651,000.00
Revenue This Year
$14.68
$58.91
Revenue Next Year
$5.73
N/A
P/E Ratio
$12.80
$3.22
Revenue Growth
10.45
20.27
52 Week Low
$28.21
$5.01
52 Week High
$46.92
$11.55

Technical Indicators

Market Signals
Indicator
BKU
NVAX
Relative Strength Index (RSI) 64.89 43.34
Support Level $45.33 $6.36
Resistance Level $46.33 $6.76
Average True Range (ATR) 0.94 0.22
MACD -0.11 0.05
Stochastic Oscillator 44.89 47.39

Price Performance

Historical Comparison
BKU
NVAX

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: